Claritin and Hyperthermia for Women aged 50-59 (a phase IV clinical study of FDA data)

Summary:

Hyperthermia is found for women aged 50-59 who take Claritin (loratadine). This study is created by eHealthMe based on reports of 6,074 women aged 50-59 from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:

Time on Claritin when people have Hyperthermia
Top conditions
Top co-used drugs
Top other side effects

On Aug, 03, 2026

6,074 women aged 50-59 reported to have side effects when taking Claritin.
Among them, 267 people (4.4%) have Hyperthermia

What is Claritin?

Claritin has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 77,316 Claritin users. Check the latest studies of Claritin.

What is Hyperthermia?

Hyperthermia (body temperature greatly above normal) is found to be associated with 4,538 drugs and 6,207 conditions by eHealthMe. Check the latest studies of Hyperthermia.

Number of reports submitted per year:

Could Claritin cause Hyperthermia in women aged 50-59?

Time on Claritin when people have Hyperthermia *

Severity of Hyperthermia

n/a

How people recovered from Hyperthermia

n/a

Top conditions involved for these people *:

You may use this to check any potential undetected conditions.

Pain: 32 people, 11.99%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 20 people, 7.49%
Breast Cancer: 18 people, 6.74%
Hypersensitivity: 18 people, 6.74%
Fibromyalgia (a long-term condition which causes pain all over the body): 17 people, 6.37%
Asthma: 16 people, 5.99%
Seasonal Allergy (allergic condition due to certain season): 16 people, 5.99%
Constipation: 13 people, 4.87%
High Blood Pressure: 12 people, 4.49%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 12 people, 4.49%

Top co-used drugs for these people *:

You may use this to check any potential interacting drugs.

Top other side effects for these people *:

You may use this to check any potential undetected side effects.

Pain: 105 people, 39.33%
Fatigue (feeling of tiredness): 104 people, 38.95%
Nausea (feeling of having an urge to vomit): 86 people, 32.21%
Headache (pain in head): 74 people, 27.72%
Weakness: 59 people, 22.10%
Joint Pain: 59 people, 22.10%
Rashes (redness): 59 people, 22.10%
Chest Pain: 57 people, 21.35%
Malaise (a feeling of general discomfort or uneasiness): 55 people, 20.60%
Stress And Anxiety: 55 people, 20.60%

* Approximation only. Some reports may have incomplete information.

Do you take Claritin and have Hyperthermia?

- Check whether Hyperthermia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies:

Claritin and Hyperthermia

How the study uses the data?

The study is based on (applicable) gender, age, loratadine (the active ingredients of Claritin) and Claritin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.